WC9-96112-06330
2 vaccinations
1 coded response
22 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 336 / FL
- Registered
- 2021-03-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Dose 1 — Pfizer-BioNTech
-
2021-03-14
Registered in v-safe
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-26
-
2021-04-02
Dose 2 — Pfizer-BioNTech
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-16
- 2021-04-24
- 2021-04-30
- 2021-05-07
- 2021-05-14
-
2021-07-02
Survey response — 3 months, dose 2MedDRA: Gestational diabetes — Feeling: GoodFree text: Diagnosed with gestational diabetesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2022-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Pfizer-BioNTech | |
| 2 | 2021-04-02 | Pfizer-BioNTech |
Free text
Release 9 — 3 months, dose 2
Symptoms: Diagnosed with gestational diabetes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gestational diabetes | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release